Library / Laws / 113th Congress / Senate Bills / S. 214
S. 214
To prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2013-02-04 | 17.2K | ⠃⠗⠋ |